webinar: what do the new dea pharmaceutical regulations mean for your organization?
Published 9 years ago • 333 plays • Length 59:08Download video MP4
Download video MP3
Similar videos
-
1:01:16
webinar: demystifying the new epa hazardous pharmaceutical waste rule
-
48:21
webinar — ethnobridging in phase i clinical trials
-
58:03
webinar: optimize your pharmaceutical waste program
-
54:48
webinar for community agencies: the dea's final rule on disposal of controlled substances
-
1:02:01
webinar: a pan-canadian pharmaceutical alliance (pcpa) update – optimizing the process for patients
-
56:41
consultation on drug reviews: webinar for patient groups
-
56:39
ms activist webinar: what does the new drug pricing law mean for you?
-
1:11:50
webinar: what soaring drug prices mean for patients
-
51:21
knowledge for change: an introduction to access to generic hepatitis c medicines
-
1:29:33
webinar on rational use of medicines
-
53:20
webinar: lab relocation
-
48:40
fda's drug product listing no change certification webinar
-
51:21
epcs webinar: controlled substance prescription monitoring program webinar - december 2019
-
58:14
olaw webinar: regulatory considerations for using pharmaceutical products...
-
![[webinar] half the battle won with new child-friendly tb drugs: what's the other half?](https://i.ytimg.com/vi/dp6ZtklMD9s/mqdefault.jpg)
58:14
[webinar] half the battle won with new child-friendly tb drugs: what's the other half?
-
56:27
rising drug trends in the us and ky: christopher a. kresnak, supervisory diversion investigator, dea
-
59:23
webinar: confronting the opioid crisis at the state level
-
59:40
epcs webinar: controlled substance prescription monitoring prgm req. & benefits–08/20 (repeat 05/20)